Levoleucovorin Patent Expiration

Levoleucovorin was first introduced by Acrotech Biopharma Inc in its drug Khapzory on Oct 19, 2018.

Levoleucovorin Patents

Given below is the list of patents protecting Levoleucovorin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Khapzory	US11541012	Compositions comprising disodium levofolinate	Mar 25, 2039	Acrotech Biopharma

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List